Sponsors often face delays when CROs and clinical sites operate separately.
Wakefield Clinical Research integrates clinical operations and site execution within one organization, improving communication, efficiency, and study timelines.
Benefits for Sponsors
• Faster study startup
• Direct coordination between CRO and site teams
• Reduced operational cost
• Direct access to experienced leadership
• Flexible support for emerging biotech companies
Study Design & Protocol Development
Regulatory Strategy & IND Support
Project Management
Clinical Operation
Clinical Monitoring
Data Management & Biostatistics
Medical Writing & Regulatory Submissions
Wakefield Clinical Research operates an active clinical trial site supporting early-phase and specialty clinical studies.
Capabilities include:
• Phase I–II clinical studies (healthy volunteers and patients)
• PK and drug-drug interaction studies
• Intensive PK sampling
• Experienced investigators and study coordinators
Oncology
Infectious disease
CNS/Neurology
Cardiovascular
Metabolic & Endocrine
Respiratory
Gastrointestinal
Dermatology
Ophthalmology
• Integrated CRO + Clinical Trial Site
• Faster study startup and execution
• Direct communication with study leadership
• Flexible support for emerging biotech sponsors
• Strong regulatory strategy expertise